FDA's Alzheimer's mistake already worsening

The Grand Island Independent

Jul 14, 2021

When the U.S. Food and Drug Administration approved Biogen Inc.'s controversial Alzheimer's drug Aduhelm without firm evidence that the drug helps patients, it created concern that…